All Market Research Reports

Explore our complete collection of market research reports, including summaries and detailed insights for every industry.

All Market Research Reports

Showing 10 of 30 reports

Personal Care

From $2999 onwards

Near packaged optics market reached US$504.54 million in 2025 and is projected to reach US$4.68 billion by 2035, growing at a 25.0% CAGR during 2026–2035.

The global near packaged optics market is segmented based on the component, optical engine technology, optical engine configuration, packaging approach, data rate, lane speed, optical interface / fiber configuration, modulation technology, application, end-user and region.

Published: 29 September, 2026
View report

Others

From $2999 onwards

Glutaminyl cyclase inhibitor therapy market was pre-commercial in 2025 and is projected to reach US$1.76 billion by 2035 as QPCT and QPCTL therapies advance toward commercialization.

The global glutaminyl cyclase inhibitor therapy market is segmented based by indication, target enzyme, treatment approach, treatment line, disease stage, patient type, route of administration, therapy setting, end user, distribution channel, development stage, and region.

Published: 29 September, 2026
View report

Others

From $2999 onwards

DNA polymerase theta therapy market reached US$136.74 million in 2025 and is projected to reach US$3.03 billion by 2035, driven by Polθ inhibitors and synthetic-lethality strategies.

The global DNA polymerase theta therapy market is segmented based on the therapeutic modality, target domain, treatment approach, cancer type, biomarker profile, disease stage, line of therapy, prior PARP inhibitor exposure, end user and distribution channel, development stage, and region.

Published: 28 September, 2026
View report

Others

From $2999 onwards

Next-generation obesity drugs market reached US$23.13 billion in 2025 and is projected to reach US$121.01 billion by 2035, driven by oral GLP-1s, multi-agonists and amylin therapies.

The global next generation obesity drugs market is segmented based on the drug class, route of administration, formulation, dosing frequency, development stage, molecular target, therapeutic objective, patient age, patient gender, distribution channel, end-user and region.

Published: 28 September, 2026
View report

Looking for something specific?

Find the exact market research report or insight you need in our database.